Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P29
Within normal range
vs 2Y Ago
-1.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-81.07%
202339.25%
202242.56%
2021-17.04%
2020-107.81%
2019-196.41%
2018-1.97%
20170.00%